Update on intracavitary radiation in the treatment of XXXX .

@entity1 @entity30365 @entity2735 @entity5 @entity150
A 15-year experience with intracavitary radiation for the treatment of selected @entity150 is presented. The age range of these @entity1 was 39 to 91 years, with an average of 65 years. There were 38 @entity1 and 17 @entity1 with multiple stage A @entity150 and @entity2735 . Some @entity1 were poor risks for treatment by total extirpative surgery. A simplified technique using a 25 mg. @entity30365 capsule as a central source is described for administration of 4,000 to 5,000 rad to the surface of the bladder. Most @entity1 tolerate the presence of the radium catheter with little difficulty. No morbidity and no mortality were reported. In this series more than 60 per cent of the @entity1 benefited from the therapy, with no recurrence noted in some cases after up to 8 1/2 years of followup. Intracavitary radiation is used in few clinics. Use of this modality does not preclude or complicate the subsequent use of other conservative measures or radical therapy if required. It is an effective procedure for treatment of multiple superficial and noninvasive @entity5 , including primary or recurrent @entity2735 , that are uncontrolled by other conservative measures.
